Zoetis Inc. IPO Info

Zoetis Inc.

Company Name: Zoetis Inc.
Stock Symbol: ZTS
Exchange: NYSE
Status: Priced
IPO Date: 2/1/2013
IPO Price: 26.00 (25.73%)
Underwriters
J.P. Morgan, BofA Merrill Lynch, Morgan Stanley

Amount of Offering: N/A
Number of Shares Offered: 86.1 Mil
Shares Outstanding After Offering: 413.9 Mil
Valuation: N/A
Company Description
Zoetis is a global leader in the discovery, development, manufacture and commercialization of animal health medicines and vaccines, with a focus on both livestock and companion animals. Pfizer holds a large stake in the company.
Financial Data
For the nine months ended September 30, 2012, revenues were $3.2 billion, reflecting growth of 2% compared to the nine months ended October 2, 2011. For the years ended December 31, 2011 and 2010, revenues were $4.2 billion and $3.6 billion, reflecting growth of 18% and 30% compared to the prior year periods. For the nine months ended September 30, 2012, Adjusted net income (a non-GAAP financial measure) was $482 million, reflecting growth of 27% compared to the nine months ended October 2, 2011. In 2011 and 2010, Adjusted net income was $503 million and $275 million, reflecting growth of 83% and 46% compared to the prior year period.

SEC Filings

News Headlines